Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2017Immunological Reviews

LAG3 (CD223) as a cancer immunotherapy target

View Full Paper
Ask AI
Bookmark
Share

Authors

LALawrence P. AndrewsAxcella Health (United States)AMAriel E. MarciscanoMassachusetts General Hospital
Charles G. Drake
Charles G. DrakeUniversité Paris-Sud

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Andrews et al. (2017) studied this question.

synapsesocial.com/papers/6a01bd86bd6301933f5cb712https://doi.org/10.1111/imr.12519
View Full Paper
Ask AI
Bookmark
Share